Lobbying

Reflexion Medical's latest lobbying report covers Q2 2026, at $60K. The four quarters Q4 2025–Q3 2026 total $180K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.

Reflexion Medical

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$180K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Reflexion Medical lobbying by quarter
Reflexion Medical lobbying by quarter
QuarterAmountReports
Q4 2022$60K1
Q1 2023$60K1
Q2 2023$60K1
Q3 2023$60K1
Q4 2023$60K1
Q1 2024$60K1
Q2 2024$60K1
Q3 2024$60K1
Q4 2024$60K1
Q1 2025$60K1
Q2 2025$60K1
Q3 2025$60K1
Q4 2025$60K1
Q1 2026$60K1
Q2 2026$60K1
Q3 2026$00

By issue

  • Health issues$510K · 15 reports
  • Medicare and Medicaid$390K · 13 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports
  • Executive Office of the President (EOP)6 reports
  • Health & Human Services, Dept of (HHS)4 reports

Firms it paid

Firm
Kountoupes Denham Carr & Reid$900K15 quarters

Former officials lobbying for it

Former position
LESLIE ZELENKODeputy Assistant Secretary for Legislation, Senior Advisor/Congressional Liaison-HHS; Legislative Director,Senior Legislative Assistant,Legislative Assistant,Legislative Correspondent-Cong. Mark Pocan, D-WI; Staff Assistant-Cong. Tammy Baldwin, D-WIQ4 2023

Lobbying reports

Filed by
07/09for Q2Kountoupes Denham Carr & Reid$60K
04/15for Q1Kountoupes Denham Carr & Reid$60K
01/16for Q4 2025Kountoupes Denham Carr & Reid$60K
25/10/14for Q3 2025Kountoupes Denham Carr & Reid$60K
25/07/18for Q2 2025Kountoupes Denham Carr & Reid$60K
25/04/15for Q1 2025Kountoupes Denham Carr & Reid$60K
25/01/17for Q4 2024Kountoupes Denham Carr & Reid$60K
24/10/17for Q3 2024Kountoupes Denham Carr & Reid$60K
24/07/15for Q2 2024Kountoupes Denham Carr & Reid$60K
24/04/09for Q1 2024Kountoupes Denham Carr & Reid$60K
24/01/16for Q4 2023Kountoupes Denham Carr & Reid$60K
23/10/11for Q3 2023Kountoupes Denham Carr & Reid$60K
23/07/18for Q2 2023Kountoupes Denham Carr & Reid$60K
23/04/19for Q1 2023Kountoupes Denham Carr & Reid$60K
23/01/19for Q4 2022Kountoupes Denham Carr & Reid$60K